Chad Messer
Stock Analyst at Lake Street
(0.91)
# 3,735
Out of 5,090 analysts
29
Total ratings
31.03%
Success rate
-15.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSTX OS Therapies | Maintains: Buy | $18 → $17 | $1.92 | +785.42% | 2 | Nov 18, 2025 | |
| GNLX Genelux | Initiates: Buy | $16 | $4.64 | +244.83% | 1 | Oct 21, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $106 | $80.38 | +31.87% | 1 | Sep 23, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Buy | $4 → $75 | $5.42 | +1,283.76% | 2 | Aug 15, 2025 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $7 | $0.99 | +605.57% | 1 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Initiates: Buy | $16 | $6.02 | +165.78% | 1 | Jul 9, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.75 | +566.67% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $19.76 | +16.40% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $3.73 | +2,956.30% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $105.63 | -52.66% | 1 | Jul 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $48 | $65.67 | -26.91% | 2 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $44.36 | -32.37% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $71.63 | -30.20% | 1 | Jun 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $10.56 | +174.62% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.06 | +385.44% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $81.68 | +5.29% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $18.09 | +143.23% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $22.26 | +645.73% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $1.54 | +1,068.83% | 1 | May 5, 2020 |
OS Therapies
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $17
Current: $1.92
Upside: +785.42%
Genelux
Oct 21, 2025
Initiates: Buy
Price Target: $16
Current: $4.64
Upside: +244.83%
Monopar Therapeutics
Sep 23, 2025
Initiates: Buy
Price Target: $106
Current: $80.38
Upside: +31.87%
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4 → $75
Current: $5.42
Upside: +1,283.76%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $0.99
Upside: +605.57%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $6.02
Upside: +165.78%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.75
Upside: +566.67%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $19.76
Upside: +16.40%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $3.73
Upside: +2,956.30%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $105.63
Upside: -52.66%
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $65.67
Upside: -26.91%
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $44.36
Upside: -32.37%
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $71.63
Upside: -30.20%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $10.56
Upside: +174.62%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.06
Upside: +385.44%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $81.68
Upside: +5.29%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $18.09
Upside: +143.23%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $22.26
Upside: +645.73%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $1.54
Upside: +1,068.83%